title: Consensus statement on the management of dyslipidaemias in adults.
authors.affiliation: Service de nutrition, maladies métaboliques, endocrinologie, hôpital de la Conception, CHU de Marseille, AP-HM, 13009 Marseille, France.
authors.forename: S
authors.initials: S
authors.lastname: Béliard
authors.affiliation: Service d'endocrinologie-diabétologie, Inserm U1018, université Rennes 1, CHU de Rennes, Rennes, France.
authors.forename: F
authors.initials: F
authors.lastname: Bonnet
authors.affiliation: Pôle CVM, service d'HTA et thérapeutique, CHU Rangueil, université de Toulouse 3, 331059 Toulouse, France.
authors.forename: B
authors.initials: B
authors.lastname: Bouhanick
authors.affiliation: Service d'endocrinologie, hôpital Pitié Salpêtrière, Paris, France.
authors.forename: E
authors.initials: E
authors.lastname: Bruckert
authors.affiliation: Inserm UMR 1087, clinique d'endocrinologie, Institut du thorax, université de Nantes, CHU de Nantes, 44000 Nantes, France.
authors.forename: B
authors.initials: B
authors.lastname: Cariou
authors.affiliation: Fédération d'endocrinologie, GHE, HCL, université de Lyon 1, Inserm UMR 1060 CARMEN, 60003 Lyon, France.
authors.forename: S
authors.initials: S
authors.lastname: Charrière
authors.affiliation: Pôle thoracique cardiovasculaire et neurologique, hôpital Robert-Debré, 51092 Reims, France.
authors.forename: V
authors.initials: V
authors.lastname: Durlach
authors.affiliation: Fédération d'endocrinologie, GHE, HCL, université de Lyon 1, Inserm UMR 1060 CARMEN, 60003 Lyon, France. Electronic address: Philippe.moulin@chu-lyon.fr.
authors.forename: P
authors.initials: P
authors.lastname: Moulin
authors.affiliation: Service de nutrition, maladies métaboliques, endocrinologie, hôpital de la Conception, CHU de Marseille, AP-HM, 13009 Marseille, France.
authors.forename: R
authors.initials: R
authors.lastname: Valéro
authors.affiliation: Pôle thoracique cardiovasculaire et neurologique, hôpital Robert-Debré, 51092 Reims, France; Service d'endocrinologie, diabétologie et maladies métaboliques, CHU de dijon, INSERM LNC UMR 866, Université Bourgogne Franche-Conté, 21000 Dijon, France.
authors.forename: B
authors.initials: B
authors.lastname: Vergès
mesh_terms: D000328:Adult; D002318:Cardiovascular Diseases / Q000097:blood / Q000209:etiology / Q000517:prevention & control; D008078:Cholesterol, LDL / Q000097:blood; D003952:Diagnostic Imaging / Q000379:methods; D003940:Diagnostic Techniques, Endocrine / Q000592:standards; D050171:Dyslipidemias / Q000150:complications / Q000628:therapy*; D004704:Endocrinology / Q000379:methods / Q000592:standards; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D025202:Molecular Diagnostic Techniques
chemical_list: D008078:Cholesterol, LDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors
keywords: Cardiovascular risk; Consensus statement; Dyslipidemia; Fibrates; LDLc goal; Statins